Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome

This study was to compare the efficacy and safety of combined glycoprotein IIb/IIIa inhibitor (GPI) and ticagrelor versus ticagrelor in patients with acute coronary syndrome (ACS). An observational study was conducted using the Improving Care for Cardiovascular Disease in China-ACS project. Totally,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Xie, Zhi-Jiang, Xin, Shuan-Li, Chang, Chao, Zhou, Hai-Jing, Zhao, Xiu-Feng, Jiao, Feng-Hui, Chen, Chuan, Li, Tao
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7853481/
https://ncbi.nlm.nih.gov/pubmed/33529262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0246166
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars